RBC Capital analyst Deane Dray raised the firm’s price target on Xylem to $162 from $157 and keeps an Outperform rating on the shares after its Q1 earnings beat. Key positives this quarter included 22% organic sales growth at Measurement and Control Solutions segment with over 550 bps of EBITDA margin expansion, book-to-bill of 1.1 times, and a 20-year build-own-operate outsourcing contract announcement with a hydrogen plant, the analyst tells investors in a research note.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on XYL:
- Xylem raises FY24 adjusted EPS view to $4.10-$4.25 from $4.00-$4.20
- Xylem reports Q1 adjusted EPS 90c, consensus 84c
- Extra Space Storage, Xylem, First Solar could break out, Barron’s says
- Xylem price target raised to $139 from $126 at Citi
- Xylem price target raised to $143 from $138 at Wolfe Research